M. Kh. Levitman

516 total citations
28 papers, 407 citations indexed

About

M. Kh. Levitman is a scholar working on Cardiology and Cardiovascular Medicine, Biochemistry and Organic Chemistry. According to data from OpenAlex, M. Kh. Levitman has authored 28 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 7 papers in Biochemistry and 6 papers in Organic Chemistry. Recurrent topics in M. Kh. Levitman's work include Renin-Angiotensin System Studies (7 papers), Eicosanoids and Hypertension Pharmacology (6 papers) and Hormonal Regulation and Hypertension (5 papers). M. Kh. Levitman is often cited by papers focused on Renin-Angiotensin System Studies (7 papers), Eicosanoids and Hypertension Pharmacology (6 papers) and Hormonal Regulation and Hypertension (5 papers). M. Kh. Levitman collaborates with scholars based in Russia and Kazakhstan. M. Kh. Levitman's co-authors include V. V. Shaposhnikova, A. A. Kudryavtsev, Yu. A. Kim, Abdujalil Narimanov, Alexei Gapeev, А. Н. Мурашев, Olga Grichenko, В. Б. Садовников, Alexander Pushin and Н. К. Чемерис and has published in prestigious journals such as FEBS Letters, International Journal of Radiation Oncology*Biology*Physics and European Journal of Pharmacology.

In The Last Decade

M. Kh. Levitman

27 papers receiving 394 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Kh. Levitman Russia 11 111 66 59 53 47 28 407
Seiichi Kitani Japan 16 218 2.0× 63 1.0× 49 0.8× 62 1.2× 18 0.4× 34 636
Keith W. Ward United States 14 124 1.1× 19 0.3× 87 1.5× 97 1.8× 14 0.3× 19 584
Bruce H. Devens United States 17 242 2.2× 13 0.2× 37 0.6× 65 1.2× 33 0.7× 44 690
Motoo Kobayashi Japan 11 159 1.4× 38 0.6× 80 1.4× 21 0.4× 22 0.5× 27 503
Zhilong Wang China 12 207 1.9× 39 0.6× 42 0.7× 60 1.1× 12 0.3× 31 561
Kyaw Zaw Hein United States 11 262 2.4× 26 0.4× 32 0.5× 27 0.5× 3 0.1× 16 732
Vicente Nogués Switzerland 5 133 1.2× 15 0.2× 44 0.7× 45 0.8× 88 1.9× 7 469
H. Müller Germany 14 414 3.7× 56 0.8× 24 0.4× 32 0.6× 15 0.3× 21 721
Christine Hanselmann Germany 6 429 3.9× 49 0.7× 35 0.6× 22 0.4× 2 0.0× 6 635

Countries citing papers authored by M. Kh. Levitman

Since Specialization
Citations

This map shows the geographic impact of M. Kh. Levitman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Kh. Levitman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Kh. Levitman more than expected).

Fields of papers citing papers by M. Kh. Levitman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Kh. Levitman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Kh. Levitman. The network helps show where M. Kh. Levitman may publish in the future.

Co-authorship network of co-authors of M. Kh. Levitman

This figure shows the co-authorship network connecting the top 25 collaborators of M. Kh. Levitman. A scholar is included among the top collaborators of M. Kh. Levitman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Kh. Levitman. M. Kh. Levitman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Kim, Yu. A., et al.. (2020). Effects of Catechin on Activity of Angiotensin-Converting Enzyme and Generation of Reactive Oxygen Species in Rat Aorta. Bulletin of Experimental Biology and Medicine. 168(5). 627–630. 4 indexed citations
3.
Kim, Yu. A., et al.. (2018). Flavonoids decrease the radiation-induced increase in the activity of the angiotensin-converting enzyme in rat aorta. European Journal of Pharmacology. 837. 33–37. 10 indexed citations
4.
Levitman, M. Kh., et al.. (2018). Blood Pressure Changes After Exposures Increasing Angiotensin-Converting Enzyme Activity and After Its Normalization with Dihydroquercetin in Male Wistar Rats. Bulletin of Experimental Biology and Medicine. 166(1). 31–34. 1 indexed citations
5.
Levitman, M. Kh., et al.. (2018). Ionizing Radiation Enhances Activity of Angiotensin-Converting Enzyme in Rat Aorta. Bulletin of Experimental Biology and Medicine. 165(2). 216–219. 11 indexed citations
6.
Kim, Yu. A., et al.. (2018). Dihydroquercetin and Fucoidin Inhibit the Increase of Angiotensin-Converting Enzyme Activity in the Rat Aorta after Irradiation. Bulletin of Experimental Biology and Medicine. 165(3). 360–363. 7 indexed citations
7.
Bibikova, Marina, et al.. (2017). Lipoxygenase Inhibitors Nordihydroguaiaretic Acid and Fungus Lecanicillum lecanii Extract Induce Death of Lymphoid Leukemia Cells. Bulletin of Experimental Biology and Medicine. 163(3). 330–333. 5 indexed citations
8.
Мурашев, А. Н., et al.. (2016). Dihydroquercetin Does Not Affect Age-Dependent Increase in Blood Pressure and Angiotensin-Converting Enzyme Activity in the Aorta of Hypertensive Rats. Bulletin of Experimental Biology and Medicine. 161(5). 670–673. 8 indexed citations
9.
Levitman, M. Kh., et al.. (2016). Taxifolin and Fucoidin Abolish the Irradiation-Induced Increase in the Production of Reactive Oxygen Species in Rat Aorta. Bulletin of Experimental Biology and Medicine. 160(5). 635–638. 15 indexed citations
10.
Levitman, M. Kh., et al.. (2014). Camel Thorn Extract Reduces Activity of Angiotensin-Converting Enzyme in Rat Aorta Increased during Aging and Treatment with NO-Synthase Inhibitor. Bulletin of Experimental Biology and Medicine. 158(2). 222–224. 2 indexed citations
13.
Levitman, M. Kh., et al.. (2004). Avermectins inhibit multidrug resistance of tumor cells. European Journal of Pharmacology. 493(1-3). 57–64. 45 indexed citations
14.
Levitman, M. Kh., et al.. (2004). Antitumor effect of avermectins. European Journal of Pharmacology. 501(1-3). 19–23. 43 indexed citations
15.
Grichenko, Olga, et al.. (2004). Analysis of 15-Lipoxygenase Activity in Irradiated Thymocytes. Biology Bulletin. 31(5). 423–427. 4 indexed citations
16.
Kudryavtsev, A. A., et al.. (2003). Opposite Effects of Low Oligomycin Concentrations on the Apoptosis of Normal and Tumor Cells. Doklady Biological Sciences. 392(1-6). 475–477. 5 indexed citations
17.
Shaposhnikova, V. V., et al.. (2003). Social Stress in Groups of Mice: Methods for Recording Conflicts and Their Consequences. Doklady Biological Sciences. 390(1-6). 271–273.
18.
Shaposhnikova, V. V., et al.. (1999). A Comparative Study of the Effects of Aversectin C, Abamectin and Ivermectin on Apoptosis of Rat Thymocytes Induced by Radiation and Dexamethasone. Acta Veterinaria Brno. 68(1). 23–29. 17 indexed citations
19.
Shaposhnikova, V. V., et al.. (1997). The effect of melittin on proliferation and death of thymocytes. FEBS Letters. 410(2-3). 285–288. 36 indexed citations
20.
Levitman, M. Kh., et al.. (1984). Protection of microcirculation in rat brain against late radiation injury by gammaphos. International Journal of Radiation Oncology*Biology*Physics. 10(3). 365–368. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026